NTL Biotech
Imran Qadeer has held the position of President at both NTL Biotech and NTL Laboratory. Imran began their role at NTL Laboratory in October 2010 and has continued in this position. Imran also assumed the role of President at NTL Biotech in July 2022 and is currently serving in this capacity as well.
Imran Qadeer has a Doctor of Medicine (MD) degree from DOW Medical College. Imran also holds a high school diploma from Oxford High School, with a focus on Biology. Additionally, they pursued a degree in Preventive Medicine at RUSH University.
This person is not in any teams
NTL Biotech
NTL Biotech came to fruition from our ventures at NTL Laboratory for over 8 years using all the major name-brand products and equipment on the market. As with all labs, we observed pain points in the production of assay tests and automated nucleic acid extraction by companies out of touch with ordinary laboratory staff and medical laboratory equipment. We emerged to develop our own molecular assay to make our process and tasks streamlined and sufficient for quality patient care. We set out to share our solutions across the country to offer labs and clinics the opportunity to become members of the NTL Biotech family to bring the most elevated quality care to patients in the molecular diagnostic field. Our molecular assays cover women's health, sexually transmitted infections, respiratory pathogens, and urologic infections. Our assays are best in class and offers an excellent solution for integration in high-complexity laboratories. Our extraction systems provide high-speed output applications such as viral RNA, Bacterial DNA, and DNA and RNA extraction for use in molecular diagnostics and genetic sequencing. We offer a system that can extract up to 192 specimens which is a first of its kind. We also feature extraction rates of 8 minutes for RNA, 15 minutes for DNA, and 12 minutes for dual DNA RNA extraction.